Narendra Pentu

Narendra Pentu

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2024 in Journal of AOAC INTERNATIONAL
Verified
Journal Article
Closed access
SMSiri Chandana M.
Siri Chandana M.
SKSujatha K.
Sujatha K.
AAAjitha Azhakesan
Ajitha Azhakesan
NPNarendra Pentu
Narendra Pentu
SKSonia K.
Sonia K.
Background: Analytical quality by design (AQbD) affords a systematic scaffolding to triumph a continuously validated, robust assay as well as life cycle management. The resuscitative repurposed drug favipiravir, an oral drug approved for reemerging pandemic influenza in Japan in 2014, is used for the treatment of life-threatening pathogens such as Ebola, Lassa virus, and currently COVID-19. Favipiravir is gaining a great deal of medical importance due to its pharmaceutical applications. Objective: To develop and validate a risk-based stability-indicating RP-HPLC method employing an AQbD approach using Central Composite Design (Design Expert Software 13.0) for the estimation of favipiravir. Method: The Quality Target Product Profile optimized were flow rate and mobile phase composition, thus assessing the critical analytical attributes (retention time, tailing factor, and number of theoretical plates) as the constraints of method robustness. The proposed technique was optimized with a C18 (150 × 4.6 mm, 5 µm) column and 0.1% orthophosphoric acid buffer–acetonitrile (50:50, v/v) as the mobile phase at a flow rate of 1 mL/min using diode-array detector (230 nm) eluted favipiravir at 2.3 min. Results: The optimized method validated as per ICH guideline Q2 (R1) was found to be eco-friendly, simple, precise (RSD 0.0051–1.2%), accurate (99.86–100.22%), linear (25–150 µg/mL), rugged (RSD 0.70%), and robust (RSD 0.6–1.6%) with a limit of detection and limit of quantitation of 1.140 µg/mL and 4.424 µg/mL, respectively. Conclusion: Forced degradation studies (acidic, alkaline, thermal, photolytic, and oxidative conditions) revealed the suitability of the AQbD method for the analysis of favipiravir in tablet formulation.The developed and validated AQbD method is less time consuming and can be used in the industry for routine quality control/analysis of bulk drug and marketed Favipiravir products. Highlights: A robust Design of Experiment enhanced stability-indicating analytical method was developed and validated for the estimation of favipiravir. Furthermore, the contemporary method would aid in extending the analysis of favipiravir in other formulations.

28 February 2025 in Journal of Applied Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
NPNarendra Pentu
Narendra Pentu
AAAjitha Azhakesan
Ajitha Azhakesan
PKPasupuleti Kishore Kumar
Pasupuleti Kishore Kumar
Background: Using computational tools in drug discovery advanced the research in identifying new drug candidates for the benefit of the pharmaceutical industry and assessing the safety and pharmacokinetic profiles of phytochemicals. Understanding the inflammatory mechanism is not possible, but inflammatory signal transduction by cytokines can be mitigated by using the flavonoid class of drugs like flavonols. Methodology: A molecular docking study of flavonol compounds with proteins linked with inflammation was carried out using the AutodockVina program. SwissADME and pkCSM modules were used to assess the pharmacokinetic features of plant products. Compared to commercially available NSAIDs, flavonols had more excellent molecular docking scores. Results: Calculation of ADME features of flavonols with no carcinogenicity and low oral acute toxicity level. Compared to anti-inflammatory medicines, the Rutin docking score against COX-I (-8.7 kcal/mol) and the Galangin docking score against COX-II enzymes (-9.4 kcal/mol) had higher values. Discussion: Molecular docking studies exhibited the highest docking score for COX-I is Rutin -8.7 Kcal/mol and hydrogen bond with THR-89, PRO-84, LS-468, GLY-471, PHE-470. The highest docking for COX-II is Galangin -9.4 Kcal/mol and hydrogen bonding with VAL-349 and TYR-385. ADME/T studies were performed for all the flavonols. Rutin has the highest violations in drug-likeliness studies. Conclusion: Flavonols may be more effective anti-inflammatory medicines than commercial medications. By modifying the pharmacokinetic features of plant products through diverse formulation strategies, we can get these phytochemicals to their target sites with fewer adverse effects.

7 June 2024 in Asian Journal of Pharmaceutical and Clinical Research
Verified
Journal Article
Open access
PDF file
NPNarendra Pentu
Narendra Pentu
SMSai Bindu M
Sai Bindu M
Rama Rao TadikondaRama Rao Tadikonda
Rama Rao Tadikonda
Flavonoids, present in plants, constitute a varied group of naturally occurring compounds well-known for their potential positive effects on health. These molecules present in fruits, vegetables, and beverages such as tea exhibit antioxidant, anti-inflammatory, and other bioactive properties that contribute to their positive impact on human health. In addition, flavonoids act as antioxidants, helping plants combat oxidative stress. Some flavonoids also participate in ultraviolet protection, defense against pathogens, and modulation of plant-microbe interactions. Flavonoids have a different subclass of flavones, flavonols, flavanones, flavan-3-ols, anthocyanins, and isoflavones. The term “bioavailability” describes how well the body absorbs and uses flavonoids, a broad class of plant-based chemicals. The chemical structure of flavonoids, the matrix of foods they are eaten interactions with other dietary components influence their bioavailability. This metabolism can lead to the formation of various metabolites, impacting the compounds’ bioactivity. Understanding these aspects is crucial for unlocking the full potential of flavonoids in promoting health and preventing diseases. Patents on flavonoids serve as legal protections for innovations related to these plant compounds. Companies and researchers seek patents to safeguard novel methods of extraction, synthesis, and applications ensuring exclusivity for a specified period. This exclusivity incentivizes investment in research and development, promoting the exploration of flavonoids for pharmaceuticals, food additives, and cosmetics. Ultimately, these legal protections encourage advancements in understanding and harnessing the diverse benefits of flavonoids across various industries.

1 January 2024 in The Pharma Innovation
Verified
Journal Article
Open access
PDF file
SASai Abhinav
Sai Abhinav
NPNarendra Pentu
Narendra Pentu
TRT Rama Rao
T Rama Rao
Flavonoids, a group of natural substances with variable phenolic structures, are found in fruits, vegetables, grains, bark, roots, stems, flowers, tea and wine. Flavonoids are now considered as an indispensable component in a variety of nutraceutical, pharmaceutical, medicinal and cosmetic applications. This is attributed to their anti-oxidative, anti-inflammatory, anti-mutagenic and anti-carcinogenic properties coupled with their capacity to modulate key cellular enzyme function. Flavonoid constitute one of the largest class of naturally occurring plant products mostly phenols either in the Free State or as their respective glycosides. The main constituent of flavonoid drugs are 2-phenyl-γ-benzopyrones. The family includes monomeric flavanols, flavanones, anthocyanidins, flavones, Isoflavonoid and Neoflavanoids. It is very probable that a number of herbal remedies, whose constituents are yet unknown, will be shown to contain active flavonoids, quercetin and rutin in plant Trigonella foenum seed, they are known for its anti-inflammatory properties. Most flavonoids have anti-tumor properties. Flavonoids are powerful antioxidant. Extract from onion contain quercetin which induce the cellular antioxidant system. The main aim of this review was to give an overview of the research in the field of flavonoids. The potential valuable working mechanisms of flavonoids are discussed, followed by present knowledge on the absorption, conjugation, and toxicity of these substances. The potential clinical applications of flavonoids are also discussed.

7 March 2025 in International Journal of Applied Pharmaceutics
Verified
Journal Article
Open access
PDF file
VEVaishnavi C. E.
Vaishnavi C. E.
AAAjitha Azhakesan
Ajitha Azhakesan
NPNarendra Pentu
Narendra Pentu
Objective: This contemporary research reports the fabrication, optimization, and evaluation of Fucoidan (FDN)-loaded Nanosponges (NS) based gel for the treatment of rheumatoid arthritis. Methods: Risk assessment was performed, followed by screening and optimization of NS formulation by 32 factorial design using Design-Expert® software. FDN-loaded NS prepared by emulsion solvent evaporation technique was subjected to different solid and liquid state characterizations and subsequently loaded in carbopol gel. The effects of pro-inflammatory cytokines (IL-1 and TNFα) were evaluated using macrophage cells. Results: The physical and chemical characteristics exhibited by the prepared NS and gels (F1-F9) were found to be optimal. The optimization resulted in achieving formulation NS1 with 72.6% in vitro drug release and 8457cp viscosity and followed the Higuchi-matrix model. Histopathology studies revealed that prepared nanogel has promising anti-arthritic activity. The skin permeation studies showed that the optimized gel formulation was successful in stopping the drug from permeation through the skin. Moreover, the nanogel has depicted sustained drug release till 24 h. Conclusion: Hence, the NS-based the delivery system developed and assessed in the current research approach seemed to be auspicious concerning preventing rheumatoid arthritis along with practical utilization in the pharmaceutical field.

23 April 2025 in International Journal of Pharmaceutical Investigation
Verified
Journal Article
Open access
PDF file
NPNarendra Pentu
Narendra Pentu
GNGaddam Namitha
Gaddam Namitha
KCKalluru Udaya Chandrika
Kalluru Udaya Chandrika
KRKolapuri Abhinav Ram
Kolapuri Abhinav Ram
VVVenkata Rajesham Vallala
Venkata Rajesham Vallala
Rama Rao TadikondaRama Rao Tadikonda
Rama Rao Tadikonda
Cancer is not a single disease, it is a multifaced malignant tumor, having ability to develop in any part of our body and it can spread to the distant regions with the high-end cell proliferation within short duration of time. As per WHO statistics in 2023, 1 in 6 deaths occurred globally caused by cancer. Out of the available treatments to treat cancer like surgery, radiotherapy, chemotherapy, stem cell, targeted drug therapy, most promising and lifelong treatment continued by the chemotherapy agents. These drugs continuous usage may leads to the Multi Drug Resistance (MDR) and toxic effects. Application of nano therapeutical treatment with lipid vesicular systems may provide the less toxic effects, increased permeation into tumor cells, avoid the MDR effect. Lipid vesicular systems like liposomes, ethosomes and transferosomes are some of the leading drug delivery systems. Modification on the surface of the lipid layer can change the drug pharmacokinetic properties to achieve the maximum bioavailability and reduce the risk of toxicity. Plant based drugs delivery through the lipid vesicles is the majorly concerned to benefit the cancer patient with the improved nutritional support and less toxic nature of chemical compounds.